Total Payments
$38,237
2024 Payments
$6,237
Companies
80
Transactions
1,485
Medicare Patients
8,256
Medicare Billing
$19.8M
Payment Breakdown by Category
Food & Beverage$23,116 (60.5%)
Other$9,317 (24.4%)
Gifts$2,859 (7.5%)
Consulting$2,138 (5.6%)
Travel$752.00 (2.0%)
Education$56.12 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,116 | 1,445 | 60.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,317 | 27 | 24.4% |
| Gift | $2,859 | 1 | 7.5% |
| Consulting Fee | $2,138 | 3 | 5.6% |
| Travel and Lodging | $752.00 | 1 | 2.0% |
| Education | $56.12 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $11,432 | 84 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $4,048 | 82 | $0 (2024) |
| UCB, Inc. | $2,966 | 145 | $0 (2024) |
| ABBVIE INC. | $1,963 | 173 | $0 (2024) |
| ARGENX US, INC. | $1,639 | 33 | $0 (2024) |
| PFIZER INC. | $1,126 | 85 | $0 (2024) |
| Amgen Inc. | $889.93 | 54 | $0 (2024) |
| Acorda Therapeutics, Inc | $820.79 | 48 | $0 (2023) |
| CSL Behring | $808.01 | 28 | $0 (2024) |
| Genentech USA, Inc. | $753.96 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,237 | 322 | UCB, Inc. ($1,594) |
| 2023 | $5,947 | 319 | ARGENX US, INC. ($1,216) |
| 2022 | $3,670 | 243 | ABBVIE INC. ($413.53) |
| 2021 | $4,519 | 218 | Alexion Pharmaceuticals, Inc. ($1,051) |
| 2020 | $5,181 | 138 | Alexion Pharmaceuticals, Inc. ($2,986) |
| 2019 | $8,300 | 150 | Alexion Pharmaceuticals, Inc. ($6,358) |
| 2018 | $1,011 | 60 | Alexion Pharmaceuticals, Inc. ($199.80) |
| 2017 | $3,373 | 35 | Novartis Pharmaceuticals Corporation ($2,950) |
All Payment Transactions
1,485 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: PAIN | ||||||
| 12/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Neurology | ||||||
| 12/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $0.30 | General |
| Category: Neurology | ||||||
| 12/17/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 12/17/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: EPILEPSY | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $12.22 | General |
| 12/12/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Musculoskeletal | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Rare Disease | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: PAIN | ||||||
| 11/25/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.78 | General |
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Immunology | ||||||
| 11/20/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,015 | 42,267 | $13.8M | $7.0M |
| 2022 | 18 | 2,170 | 42,371 | $16.0M | $7.2M |
| 2021 | 16 | 2,066 | 31,218 | $9.9M | $5.4M |
| 2020 | 13 | 2,005 | 2,866 | $460,445 | $210,172 |
Total Patients
8,256
Total Services
118,722
Medicare Billing
$19.8M
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1300 | Injection, eculizumab, 10 mg | Office | 2023 | 16 | 38,280 | $13.0M | $6.8M | 52.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 503 | 749 | $130,582 | $63,617 | 48.7% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 276 | 277 | $112,862 | $37,504 | 33.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 22 | 387 | $237,618 | $35,628 | 15.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 174 | 174 | $52,780 | $25,805 | 48.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 372 | 761 | $110,937 | $25,568 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 162 | 175 | $21,595 | $10,343 | 47.9% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 74 | 185 | $21,887 | $9,214 | 42.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 87 | 87 | $25,950 | $8,238 | 31.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 19 | 179 | $58,286 | $7,294 | 12.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 48 | $11,960 | $6,176 | 51.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 119 | 124 | $10,100 | $5,666 | 56.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 12 | 27 | $6,075 | $2,758 | 45.4% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 38 | 38 | $3,878 | $2,453 | 63.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $5,012 | $2,228 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,523 | $1,141 | 45.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 16 | $4,800 | $824.64 | 17.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 74 | 730 | $7,300 | $561.86 | 7.7% |
| J1300 | Injection, eculizumab, 10 mg | Office | 2022 | 16 | 38,310 | $15.2M | $6.9M | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 676 | 1,075 | $155,950 | $93,772 | 60.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 22 | 351 | $215,514 | $34,740 | 16.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 223 | 223 | $78,050 | $31,882 | 40.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 183 | 183 | $40,260 | $29,298 | 72.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 340 | 686 | $113,190 | $23,873 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 201 | 215 | $21,545 | $11,248 | 52.2% |
About David White
David White is a Neurology healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1871882357.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David White has received a total of $38,237 in payments from pharmaceutical and medical device companies, with $6,237 received in 2024. These payments were reported across 1,485 transactions from 80 companies. The most common payment nature is "Food and Beverage" ($23,116).
As a Medicare-enrolled provider, White has provided services to 8,256 Medicare beneficiaries, totaling 118,722 services with total Medicare billing of $19.8M. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Huntsville, AL
- Active Since 04/05/2011
- Last Updated 08/25/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1871882357
Products in Payments
- SOLIRIS (Drug) $6,583
- Soliris (Drug) $3,107
- GILENYA (Drug) $3,004
- VYVGART (Drug) $1,451
- Briviact (Drug) $1,238
- Rystiggo (Drug) $1,216
- NURTEC ODT (Drug) $1,012
- INBRIJA (Drug) $820.79
- Hizentra (Biological) $808.01
- Aimovig (Biological) $801.75
- NUPLAZID (Drug) $746.95
- UBRELVY (Drug) $746.40
- KESIMPTA (Drug) $734.20
- NUEDEXTA (Drug) $725.22
- ULTOMIRIS (Biological) $684.55
- QULIPTA (Drug) $560.87
- GOCOVRI (Drug) $543.97
- EMGALITY (Drug) $542.06
- BOTOX (Biological) $503.90
- Gamunex-C (Biological) $430.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Huntsville
Dr. Harry Mcdaris, M.d, M.D
Neurology — Payments: $417,976
Neurology $417,976
Dr. Anjaneyulu Alapati, M.d, M.D
Neurology — Payments: $170,441
Neurology $170,441
David Greer, Md, MD
Neurology — Payments: $82,376
Neurology $82,376
Bhageeradh Mulpur, M.d, M.D
Neurology — Payments: $74,035
Neurology $74,035
Dr. Scott Hitchcock, D.o, D.O
Neurology — Payments: $44,311
Neurology $44,311
Amit Arora, M.d, M.D
Neurology — Payments: $22,201
Neurology $22,201